Cancer. For pediatric glioma, leave no histone unturned

Affiliations

¹ Division of Pediatric Hematology-Oncology, Department of Pathology, and Preston Robert Tisch Brain Tumor Center, Duke University, Durham, NC, 27710, USA. rwreya@sanfordburnham.org oren.becher@duke.edu.
² Tumor Initiation & Maintenance Program, NCI-Designated Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA, 92037, USA. rwreya@sanfordburnham.org oren.becher@duke.edu.

Comment

Oren J Becher et al. Science. 2014.

. 2014 Dec 19;346(6216):1458-9.

doi: 10.1126/science.aaa3814.

¹ Division of Pediatric Hematology-Oncology, Department of Pathology, and Preston Robert Tisch Brain Tumor Center, Duke University, Durham, NC, 27710, USA. rwreya@sanfordburnham.org oren.becher@duke.edu.
² Tumor Initiation & Maintenance Program, NCI-Designated Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA, 92037, USA. rwreya@sanfordburnham.org oren.becher@duke.edu.

No abstract available

Comment on

Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma.
Hashizume R, Andor N, Ihara Y, Lerner R, Gan H, Chen X, Fang D, Huang X, Tom MW, Ngo V, Solomon D, Mueller S, Paris PL, Zhang Z, Petritsch C, Gupta N, Waldman TA, James CD. Hashizume R, et al. Nat Med. 2014 Dec;20(12):1394-6. doi: 10.1038/nm.3716. Epub 2014 Nov 17. Nat Med. 2014. PMID: 25401693 Free PMC article.
Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation.
Funato K, Major T, Lewis PW, Allis CD, Tabar V. Funato K, et al. Science. 2014 Dec 19;346(6216):1529-33. doi: 10.1126/science.1253799. Epub 2014 Nov 20. Science. 2014. PMID: 25525250 Free PMC article.